Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-28 1:39 pm Purchase |
2021-12-31 | 13G | Sierra Oncology, Inc. SRRA |
Frazier Life Sciences VIII L.P. | 1,264,861 8.400% |
1,062,058 (+523.69%) |
Filing History |
| 2021-11-08 07:58 am Purchase |
2021-11-03 | 13D | Sierra Oncology, Inc. SRRA |
Longitude Capital Partners III LLC | 3,450,270 20.300% |
1,972,450 (+133.47%) |
Filing History |
| 2021-11-05 5:00 pm Purchase |
2021-11-05 | 13G | Sierra Oncology, Inc. SRRA |
Vivo Capital IX, LLC | 1,935,853 14.800% |
480,277 (+33.00%) |
Filing History |
| 2021-11-05 4:40 pm Purchase |
2021-11-05 | 13D | Sierra Oncology, Inc. SRRA |
Abingworth LLP | 2,043,626 12.600% |
7,874 (+0.39%) |
Filing History |
| 2021-11-05 4:26 pm Purchase |
2021-11-05 | 13D | Sierra Oncology, Inc. SRRA |
ORBIMED ADVISORS LLC | 3,044,753 18.100% |
3,033,090 (+26006.64%) |
Filing History |
| 2021-08-16 4:17 pm Purchase |
2021-08-06 | 13G | Sierra Oncology, Inc. SRRA |
Frazier Life Sciences Public Fund, L.P. | 804,667 9.500% |
804,667 (New Position) |
Filing History |
| 2021-04-01 4:56 pm Purchase |
2021-03-22 | 13G | Sierra Oncology, Inc. SRRA |
ADAGE CAPITAL PARTNERS GP LLC | 794,140 6.830% |
794,140 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Sierra Oncology, Inc. SRRA |
CAXTON CORP | 1,142,361 9.900% |
60,161 (+5.56%) |
Filing History |
| 2021-02-16 4:32 pm Purchase |
2020-12-31 | 13G | Sierra Oncology, Inc. SRRA |
Rock Springs Capital Management LP | 567,358 5.140% |
12,281 (+2.21%) |
Filing History |
| 2021-02-16 12:06 pm Sale |
2021-01-26 | 13G | Sierra Oncology, Inc. SRRA |
Mangrove Partners Master Fund Ltd. | 548,869 4.800% |
-38,595 (-6.57%) |
Filing History |
| 2021-02-16 12:00 pm Purchase |
2020-12-31 | 13G | Sierra Oncology, Inc. SRRA |
Mangrove Partners Master Fund Ltd. | 587,464 5.100% |
587,464 (New Position) |
Filing History |
| 2020-10-19 4:23 pm Purchase |
2020-10-09 | 13G | Sierra Oncology, Inc. SRRA |
Rock Springs Capital Management LP | 555,077 5.340% |
555,077 (New Position) |
Filing History |
| 2020-04-29 4:46 pm Purchase |
2020-03-03 | 13D | Sierra Oncology, Inc. SRRA |
Frazier Life Sciences VIII L.P. | 202,803 2.000% |
202,803 (New Position) |
Filing History |